| Literature DB >> 32211252 |
Faryal Tahir1, Zainab Majid1, Bushra Majid1, Jawad Ahmed1, Arbaz Zaman1, Moeez Tariq1, Fouzia Imtiaz2, Syeda Anjala Tahir1,3.
Abstract
Background Non-alcoholic fatty liver disease (NAFLD) is a common liver disorder caused by the deposition of lipids and fats in the hepatocytes, in individuals who consume little or no alcohol, which eventually progresses to cirrhosis and carcinoma. Apart from the known risk factors like obesity, metabolic syndrome (MS), and lack of physical activity (PA), diet also plays a major role in the development of NAFLD. A high body mass index (BMI) and waist circumference (WC) have positive associations with NAFLD. The aim of this study was to find the prevalence of risk factors of hepatic steatosis in NAFLD population and to raise public awareness about the condition. Method We conducted a cross-sectional study from October to December 2019 with a sample size of 98 subjects determined by using a confidence interval (CI) of 99.9%. Patients presenting to Essa Laboratory, Karachi for abdominal ultrasound (US) were scanned for fatty changes in the liver, after obtaining consent, and were then assessed for risk factors by administering a 20-item questionnaire along with registering their BMI and WC measurement. The collected data was analyzed using the Statistical Package for Social Sciences (SPSS), version 22 (IBM, Armonk, NY). The independent sample t-test was applied for the exploration of variables and a p-value <0.05 was considered significant. Result Our study included 96 participants, of which 49 (51%) were male and 47 (49%) female. Mean BMI in females was slightly greater (30.58) than in males (27.98), whereas WC (in inches) was almost equal in males (40.796) and females (40.383). Among the people that had any comorbidities (n = 60, 62.5%), hypertension (HTN) was the most common one (n = 37, 38.5%) followed by diabetes mellitus (DM) type 2 (n = 26, 27.1%). A significant majority (n = 63, 65.5%) never consumed any fruits or vegetables in their meal nor did they perform any sort of physical exercise (n = 46, 47.9%). Conclusion Obesity (high BMI), lack of PA, lower consumption of fruits and vegetables along with a carbohydrate- and fat-rich diet play a vital role in the development of hepatic steatosis. Moreover, HTN and DM, as components of MS, exhibit a significant association with NAFLD. Screening and counseling sessions should be considered for individuals with these anthropometric measurements and lifestyle characteristics.Entities:
Keywords: body mass index; cirrhosis; fatty liver; insulin resistance; metabolic syndrome; nafld; nash; non-alcoholic fatty liver disease; obesity; physical activity
Year: 2020 PMID: 32211252 PMCID: PMC7081744 DOI: 10.7759/cureus.7016
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Demographics of the participants (n = 96)
| Variables | Number of participants | Percentage (%) |
| Age (years) | ||
| 18-20 | 4 | 4.2 |
| 21-30 | 18 | 18.8 |
| 31-40 | 24 | 25.0 |
| 41-50 | 28 | 29.2 |
| 51-60 | 13 | 13.5 |
| >60 | 9 | 9.4 |
| Gender | ||
| Male | 49 | 51 |
| Female | 47 | 49 |
| Occupation | ||
| Housewife | 38 | 39.6 |
| Blue collar | 24 | 25 |
| White collar | 12 | 12.5 |
| Red collar | 4 | 4.2 |
| Pink collar | 4 | 4.2 |
| Retired | 3 | 3.1 |
| Unemployed | 5 | 5.2 |
| Students | 6 | 6.25 |
| Status | ||
| Low class | 13 | 13.5 |
| Middle class | 78 | 81.3 |
| High class | 5 | 5.2 |
Mean BMI and mean WC of participants with respect to gender and social status (n = 96)
BMI: body mass index; WC: waist circumference
| Variables | Number of participants | Mean BMI (Kg/m2) | Mean WC (Inches) | P-value |
| Gender | ||||
| Male | 49 | 27.98 | 40.796 | 0.006 (for mean BMI) |
| Female | 47 | 30.58 | 40.383 | |
| Status | ||||
| Low class | 13 | 29.05 | 40.923 | |
| Middle class | 78 | 28.94 | 40.276 | |
| High class | 5 | 34.64 | 44.700 | |
Assessment of dietary habits, lifestyle, comorbidities, and stress levels among participants (n = 96)
PA: physical activity; DM: diabetes mellitus; HTN: hypertension; CVD: cardiovascular disease: CKD: chronic kidney disease
| Questions | Options, n (%) | |||||||
| Q1. Meals consumed in a day | 1 | 2 | 3 | 4 | >4 | |||
| A1. | 2 (2.1) | 24 (25.0) | 62 (64.6) | 5 (5.2) | 3 (3.1) | |||
| Q2. Preference to eat in dinner | Only meat | Meat with rice or roti (bread) | Only rice | Others | ||||
| A2. | 8 (8.3) | 52 (54.2) | 22 (22.9) | 14 (14.6) | ||||
| Q3. Time taken to complete dinner | <10 mins | Between 10-15 mins | Between 15-25 mins | |||||
| A3. | 21 (21.9) | 58 (60.4) | 17 (17.7) | |||||
| Q4. Time of dinner | Before 9 pm | After 9 pm | At midnight | No exact time | ||||
| A4. | 25 (26.0) | 45 (46.9) | 14 (14.6) | 12 (12.5) | ||||
| Q5. Frequency of eating out | Never | Once in a month | Once in every 15 days | Once in a week | Daily | More than once in a week | ||
| A5. | 19 (19.8) | 31 (32.3) | 16 (16.7) | 18 (18.8) | 11 (11.5) | 1 (1) | ||
| Q6. Preference of meal when dining out | Not applicable | Chinese | Grilled | Barbeque | Fast food | Continental | Multiple preferences | Desi (Pakistani) |
| A6. | 19 (19.8) | 2 (2.1) | 2 (2.1) | 23 (24.0) | 19 (19.8) | 8 (8.3) | 17 (17.7) | 6 (6.3) |
| Q7. Frequency of eating fruits and vegetables | Never | Once in a month | Once in every 15 days | Once in a week | Daily | |||
| A7. | 63 (65.5) | 21 (21.9) | 4 (4.2) | 5 (5.2) | 3 (3.1) | |||
| Q8. Consumption of canned foods | Never | Once in a month | Once in every 15 days | Once in a week | Daily | |||
| A8. | 63 (65.6) | 21 (21.9) | 4 (4.2) | 5 (5.2) | 3 (3.1) | |||
| Q9. Consumption of bakery items | Never | Once in a month | Once in every 15 days | Once in a week | Daily | |||
| A9. | 16 (16.7) | 13 (13.5) | 9 (9.4) | 24 (25.0) | 34 (35.4) | |||
| Q10. Consumption of cold/sugary/fizzy drinks | Never | Once in a month | Once in every 15 days | Once in a week | Daily | More than once in a week | ||
| A10. | 20 (20.8) | 20 (20.8) | 20 (20.8) | 28 (29.2) | 7 (7.3) | 1 (1) | ||
| Q11. Frequency of workout | Never | Once in a month | Once in every 15 days | Once in a week | Daily | |||
| A11. | 46 (47.9) | 19 (19.8) | 5 (5.2) | 13 (13.5) | 13 (13.5) | |||
| Q12. Preference for medium of ascend | No Preference | Stairs | Escalator | Lift | ||||
| A12. | 13 (13.5) | 59 (61.5) | 3 (3.1) | 21 (21.9) | ||||
| Q13. Involvement of PA at occupation | Never | Sometimes | Always | |||||
| A13. | 28 (29.2) | 34 (35.4) | 34 (35.4) | |||||
| Q14. Frequency of getting irritated | Never | Sometimes | Frequently | Always | ||||
| A14. | 22 (22.9) | 40 (41.7) | 19 (19.8) | 15 (15.6) | ||||
| Q15. Sleep with a relaxed mind | No | Yes | Sometimes | |||||
| A15. | 18 (18.8) | 59 (61.5) | 19 (19.8) | |||||
| Q16. Number of causes of stress | None | A few | Too many | |||||
| A16. | 32 (33.3) | 47 (49.0) | 17 (17.7) | |||||
| Q17. Any comorbidities | No | Yes | ||||||
| A17a. | 36 (37.5) | 60 (62.5) | ||||||
| 17b. DM Type 2 | 70 (72.9) | 26 (27.1) | ||||||
| 17c. HTN | 59 (61.5) | 37 (38.5) | ||||||
| 17d. Hepatitis | 91 (94.8) | 5 (5.2) | ||||||
| 17e. CVD | 88 (91.7) | 8 (8.3) | ||||||
| 17f. CKD | 89 (92.7) | 7 (7.3) | ||||||
| 17g. Others | 86 (89.6) | 10 (10.4) | ||||||
| Q18a. Cholesterol ever tested | No | Yes | ||||||
| A18a. | 57 (59.4) | 39 (40.6) | ||||||
| 18b. If yes, what were the levels? | Not applicable | Normal | Abnormal | Not Known | ||||
| A18b. | 57 (59.4) | 23 (24.0) | 15 (15.6) | 1 (1) | ||||
| Q19a. Comorbidities in the family | None | Yes | ||||||
| Ans19a. | 18 (18.8) | 78 (81.3) | ||||||
| 19b. DM Type 2 | 52 (54.2) | 44 (45.8) | ||||||
| 19c. HTN | 45 (46.9) | 51 (53.1) | ||||||
| 19d. CVD | 65 (67.7) | 31 (32.3) | ||||||
| 19e. Hyperlipidemia | 73 (76) | 23 (24) | ||||||
| Q20a. Medications taken regularly | No | Yes | ||||||
| A20a. | 52 (54.2) | 44 (45.8) | ||||||
| 20b. Antidepressants | 92 (95.8) | 4 (4.2) | ||||||
| 20c. Antiepileptic | 94 (97.9) | 2 (2.1) | ||||||
| 20d. Diabetes medicines | 73 (76) | 23 (24) | ||||||
| 20e. Steroids | 94 (97.9) | 2 (2.1) | ||||||
| 20f. Anti-hypertensives | 64 (66.7) | 32 (33.3) | ||||||
| 20g. Others | 93 (96.9) | 3 (3.1) | ||||||
Figure 1Major comorbidities among participants (n = 60)
Figure 2Other comorbidities among participants (n = 10)